Top in hem/onc: Balancing research and patient care, boosters in people with cancer
Click Here to Manage Email Alerts
In a recent interview, Hanna Y. Irie, MD, PhD, discussed her unconventional career path as both a physician-scientist who runs an active research lab and a medical oncologist.
Irie said that it is a “constant struggle” balancing both efforts, but her patients are “the constant motivation” for finding new drug targets and new compounds for breast cancer. Her interview was the top story in hematology/oncology last week.
Another top story was about the efficacy of a third dose of a messenger RNA COVID-19 vaccine in patients with cancer who were actively undergoing chemotherapy.
Read these and more top stories in hematology/oncology below:
Breast oncologist, researcher forges uncommon career path
As a physician-scientist and medical oncologist, Hanna Y. Irie, MD, PhD, has forged an uncommon path in oncology that does not fit into typical career tracks at most academic cancer centers. Read more.
Third dose of COVID-19 vaccine increases response among patients with cancer
Patients undergoing active chemotherapy for solid tumor cancers mounted an antibody response similar to healthy individuals after a third dose of the mRNA COVID-19 vaccine, according to a study in Nature Medicine. Read more.
Point-of-Care Manufacturing Offers Treat It When You Need It Approach to CART
Numerous academic medical centers around the world have demonstrated the ability to develop and produce safe and effective chimeric antigen receptor T-cell therapies. Read more.
Earlier CAR-T treatment possible if price comes down FDA official says
Expanded use of chimeric antigen receptor T cells for cancer treatment requires that less expensive therapies be developed faster using multiple manufacturing models, according to an FDA official. Read more.
ASH releases guidelines on stem cell transplantation for patients with sickle cell disease
New guidelines for sickle cell disease issued by ASH and published in Blood Advances aim to inform practitioners and patients on the use of hematopoietic stem cell transplantation in clinical practice. Read more.